A Phase II Trial of Topotecan in Patients With Myelodysplastic Syndrome

Abstracts/Posters/Presentations:

• Daniel Vaena, Larry Cripe, Lawrence Einhorn, Paul Walker, Kenneth Pennington, Carol Young, Cindy Stoner. Phase II Study of Low-Dose Topotecan in Myelodysplastic Syndromes: A Hoosier Oncology Group Study MDS98-1. Accepted as a poster presentation for ASCO Annual Meeting May 18-21, 2002, Orlando, FL.

Manuscripts/Articles:

• Vaena DA, Walker P, Pennington K, Stephens A, Stender MJ, Yiannoutsos CT, Young C, Stoner C, Cripe LD. Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study. Leuk Res. 2004 Jan;28(1):49-52. See abstract.